OTCMKTS:VTXPF - Victrex Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 8
  • Breakdown:
  • 3 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$27.25
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New Victrex Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VTXPF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VTXPF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Victrex in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $27.25.
Hold
The current consensus among 8 investment analysts is to hold stock in Victrex.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/6/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/4/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/3/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/2/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 2 sell ratings
5/31/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 3 sell ratings
8/29/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 3 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 3 sell ratings
11/27/2020

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 3 sell ratings

DateBrokerageActionRatingPrice TargetDetails
10/7/2020CSFBReiterated RatingOutperform
i
10/7/2020Credit Suisse GroupReiterated RatingOutperform
i
8/24/2020BarclaysReiterated RatingUnderweight
i
7/22/2020Morgan StanleyReiterated RatingUnderweight
i
7/8/2020UBS GroupReiterated RatingSell
i
6/24/2020BarclaysReiterated RatingUnderweight
i
6/1/2020Liberum CapitalDowngradeBuy ➝ Hold
i
5/19/2020Jefferies Financial GroupInitiated CoverageBuy
i
5/7/2020BarclaysReiterated RatingUnderweight
i
3/30/2020Morgan StanleyReiterated RatingUnderweight
i
3/24/2020JPMorgan Chase & Co.Reiterated RatingNeutral
i
3/23/2020Morgan StanleyReiterated RatingUnderweight
i
(Data available from 11/27/2015 forward)
Victrex logo
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It offers PEEK and PAEK polymer materials; and specialist solutions for medical device manufacturers. It serves automotive, aerospace, energy, manufacturing and engineering, electronics, and medical markets. The company was incorporated in 1993 and is headquartered in Thornton Cleveleys, the United Kingdom.
Read More

Today's Range

Now: $27.25
$27.25
$27.25

50 Day Range

MA: $25.33
$24.20
$27.25

52 Week Range

Now: $27.25
$21.82
$33.55

Volume

11 shs

Average Volume

717 shs

Market Capitalization

$2.36 billion

P/E Ratio

20.04

Dividend Yield

N/A

Beta

1.37